《中国女性乳腺癌患者糖尿病和糖尿病前期管理专家共识》(2024版)  

Chinese expert consensus on management of diabetes and prediabetes in female breast cancer patients (version 2024)

作　　者：中国抗癌协会乳腺肿瘤整合康复专业委员会 中国抗癌协会肿瘤临床研究管理学专业委员会 中国医师协会外科医师分会乳腺外科专家工作组 国家肿瘤质控中心乳腺癌专家委员会 重庆市临床医学研究联合会 重庆抗癌协会肿瘤内分泌专业委员会 孔令泉[2] 卢林捷 梁馨予 张翔 程庆丰 张冬颖 Breast Cancer Rehabilitation Committee of China Anti-Cancer Association;Research Administration of China Anti-Cancer Association;Breast Surgery Expert Working Group of Surgeons Branch of Chinese Medical Doctor Association;the Breast Cancer Expert Committee of the National Cancer Quality Control Center;Chongqing Federation of Clinical Medical Research;the Society of Onco-Endocrinology of Chongqing Anti-Cancer Association;Kong Lingquan;Lu Linjie;Liang Xinyu(不详;Department of Breast and Thyroid Surgery,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China;Department of Breast and Thyroid Surgery,Liuzhou People’s Hospital Affiliated to Guangxi Medical University,Liuzhou 345000,China;Department of Hematology Oncology and Radiotherapy,Honghui Hospital of Xi’an Jiaotong University,Xi’an 710054)

机构地区：[1]不详 [2]重庆医科大学附属第一医院乳腺甲状腺外科,重庆400016 [3]广西医科大学附属柳州市人民医院乳腺甲状腺外科,柳州545000 [4]西安交通大学附属红会医院血液肿瘤放疗科,西安710054 [5]重庆医科大学附属第一医院

出　　处：《中华内分泌外科杂志（中英文）》2024年第5期593-604,共12页Chinese Journal of Endocrine Surgery

摘　　要：乳腺癌患者伴随糖尿病和糖尿病前期比例较高,将影响其生活质量和预后。随着诊治水平的改善,乳腺癌患者生存期不断延长,乳腺癌患者伴随血糖异常逐渐受到关注,但目前国内外仍缺乏针对乳腺癌患者糖尿病和糖尿病前期管理的指南或共识。中国抗癌协会乳腺肿瘤整合康复专业委员会、中国抗癌协会肿瘤临床研究管理学专业委员会、中国医师协会外科医师分会乳腺外科专家工作组、国家肿瘤质控中心乳腺癌专家委员会、重庆市临床医学研究联合会和重庆抗癌协会肿瘤内分泌专业委员会组织相关专家,基于最新相关文献、国内外相关指南、共识及多个诊疗中心的临床经验,编写《中国女性乳腺癌患者糖尿病和糖尿病前期管理专家共识》(2024版),希望通过本共识规范乳腺癌患者血糖异常的管理,提高患者的生活质量和改善预后。Diabetes and prediabetes in breast cancer patients are widespread and seriously affects the life quality and prognosis of breast cancer patients.As the overall survival of early breast cancer women continues to increase,blood glucose abnormality is getting attention gradually.However,there is still a lack of targeted guidelines or consensus for the management of diabetes and prediabetes in breast cancer patients.Based on the recent relevant references,the guideline and the clinical experience of multiple clinical centers,Breast Cancer Rehabilitation Committee of China Anti-Cancer Association,the Society of Clinical Cancer Research Administration of China Anti-Cancer Association,Breast Surgery Expert Working Group of Surgeons Branch of Chinese Medical Doctor Association,the Breast Cancer Expert Committee of the National Cancer Quality Control Center,Chongqing Federation of Clinical Medical Research,and the Society of Onco-endocrinology of Chongqing Anti-Cancer Association thoroughly discussed and formulated the Chinese Expert Consensus on Management of Diabetes and Prediabetes in Female Breast Cancer Patients(version 2024),in order to further standardize the management of patient’s blood glucose abnormality to improve the patient’s life quality and prognosis.

关 键 词：乳腺癌 糖尿病 糖尿病前期 未知晓糖尿病 口服葡萄糖耐量试验 

分 类 号：R737.9[医药卫生—肿瘤] R587.1[医药卫生—临床医学]